Compare PLYX & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLYX | RCKY |
|---|---|---|
| Founded | 2014 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.3M | 242.9M |
| IPO Year | N/A | 1996 |
| Metric | PLYX | RCKY |
|---|---|---|
| Price | $5.45 | $39.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $40.00 |
| AVG Volume (30 Days) | ★ 2.0M | 62.0K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | N/A | ★ 94.74 |
| EPS | N/A | ★ 2.96 |
| Revenue | N/A | ★ $270,408,000.00 |
| Revenue This Year | N/A | $8.12 |
| Revenue Next Year | N/A | $4.90 |
| P/E Ratio | ★ N/A | $13.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.20 | $11.97 |
| 52 Week High | $8.15 | $48.70 |
| Indicator | PLYX | RCKY |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 46.17 |
| Support Level | $2.37 | $28.57 |
| Resistance Level | $7.43 | $48.70 |
| Average True Range (ATR) | 1.11 | 1.68 |
| MACD | 0.22 | -0.93 |
| Stochastic Oscillator | 59.79 | 7.00 |
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.